Pages that link to "Q34428808"

The following pages link to Placebo effects in developmental disabilities: implications for research and practice (Q34428808):

Displaying 21 items.

• Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy (Q21563404) (← links)
• Oxytocin for Male Subjects with Autism Spectrum Disorder and Comorbid Intellectual Disabilities: A Randomized Pilot Study (Q27303760) (← links)
• Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism (Q28247116) (← links)
• Conditioned placebo dose reduction: a new treatment in attention-deficit hyperactivity disorder? (Q33986114) (← links)
• Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. (Q34157712) (← links)
• Early pharmacological treatment of autism: a rationale for developmental treatment (Q36727667) (← links)
• Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial (Q37019876) (← links)
• Comparison among clomipramine, fluoxetine, and placebo for the treatment of anxiety disorders in children and adolescents (Q37409007) (← links)
• Assessment of Cognitive Outcome Measures in Teenagers with 15q13.3 Microdeletion Syndrome (Q37717427) (← links)
• Immune dysfunction in autism: a pathway to treatment (Q37774097) (← links)
• Complementary and alternative medicine in autism: an evidence-based approach to negotiating safe and efficacious interventions with families (Q37774100) (← links)
• Placebo effects in children: a review (Q38100087) (← links)
• Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension (Q38895015) (← links)
• Brief report: Effects of pressure vest usage on engagement and problem behaviors of a young child with developmental delays (Q39994512) (← links)
• Does placebo response differ between objective and subjective measures in children with attention-deficit/hyperactivity disorder? (Q42879127) (← links)
• Placebo by proxy (Q43001958) (← links)
• The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders (Q43091869) (← links)
• Spasticity treatment facilitates direct care delivery for adults with profound intellectual disability. (Q43173977) (← links)
• Parents' and child health professionals' attitudes towards dietary interventions for children with autism spectrum disorders (Q50310809) (← links)
• Treatments for autism: parental choices and perceptions of change (Q50313813) (← links)
• Placebo by proxy expectations toward acupuncture change over time: a survey comparing parental expectations to acupuncture pre- and postoperatively. (Q55293388) (← links)